Proton beam therapy is an advanced form of external radiotherapy that uses high-energy proton beams instead of photon x-ray beams or electrons. Carefully measured doses of protons are delivered to the precise area needing treatment, using the latest IBA ProteusONE technology. This ensures that the delivery of proton beam therapy is highly accurate and prevents the risk of radiation reaching surrounding healthy tissue.
Radiotherapy is used to kill and destroy cancer cells. It utilises radiation in the form of high-energy x-rays, known as photons, to kill and damage the cancerous cells and prevent their growth and reproduction. It can be used as a non-surgical option to treat cancer, and it can also be used to shrink a tumour or in combination with other treatments.
The Rutherford Cancer Centres and Elekta are bringing the next generation of personalised adaptive radiotherapy technology to oncology centres across the UK, with the new MR-linac Elekta Unity available at the Rutherford Cancer Centre North West in Liverpool from late 2020.
The Rutherford Cancer Centres are at the forefront of innovative cancer care with their UK network of centres.
The Rutherford Cancer Centres operate a network of cancer centres, nationally and internationally, providing all-encompassing cancer services for patients. Our vision is to transform cancer care for patients by providing personalised and holistic support.
The centres deliver high-quality diagnostic imaging and the latest in advanced cancer treatments including radiotherapy, chemotherapy, immunotherapy and, in the future, proton beam therapy across all centres. Every patient that comes to a Rutherford Cancer Centre is provided with a personalised and tailored treatment plan and their own support team. As part of the ‘Rutherford’s networked, centralised system’, patients can attend any of the centres according to their needs, with the option to attend the care oncology clinic at one centre and travel to another for treatment as necessary.
Rutherford Cancer Centres are built and managed by Rutherford Health plc, the forerunners in innovative cancer care and leading developers of proton beam therapy centres in the UK and beyond. The centres take their name from renowned scientist and Noble Prize winner, Ernest Rutherford, whose contribution to identifying (1909-1919) and naming of the proton (1920) saw him recognised as the father of nuclear physics.
In 2017, Rutherford opened their first UK centre in Newport, South Wales, known as the Rutherford Cancer Centre South Wales. South Wales became the first cancer centre in the UK to officially offer high energy proton beam therapy, making great leaps in the innovation of cancer care after treating the first patient with proton therapy in the UK in April 2018.
In December 2018, Rutherford Cancer Centre South Wales was the first Rutherford centre to be approved by the Welsh Health Specialised Services Committee (WHSSC) to provide high energy proton beam therapy as a treatment to adults referred from the NHS in Wales.
During 2018, the Rutherford Cancer Centre network expanded to include the Rutherford Cancer Centre North East in Bedlington, Northumberland, which started to offer proton beam therapy treatments to adults in the UK from May 2019. The Rutherford Cancer Centre Thames Valley in Shinfield, Reading, also opened in 2019 and began treating its first proton beam therapy patients from August 2019.
Late 2018 also saw the initial development of a new centre, the Rutherford Cancer Centre North West, which will open in Liverpool’s Knowledge Quarter development, near to the city hospital and university. The centre is scheduled to open in 2020.
Our aim is to provide the majority of patients with a state-of-the-art cancer centre within a ninety-minute journey of their front door, wherever they are in the UK.